Literature DB >> 18365267

GCG-rich tea catechins are effective in lowering cholesterol and triglyceride concentrations in hyperlipidemic rats.

Sang Min Lee1, Chae Wook Kim, Jung Kee Kim, Hyun Jung Shin, Joo Hyun Baik.   

Abstract

The (-)-gallocatechin gallate (GCG) concentration in some tea beverages can account for as much as 50% of the total catechins, as a result of sterilization. The present study aims to examine the effects of GCG-rich tea catechins on hyperlipidemic rats and the mechanisms associated with regulating cholesterol metabolism in the liver. By performing heat epimerization of (-)-epigallocatechin gallate (EGCG), we manufactured a mixture of catechins that had a GCG content of approximately 50% (w/w). In sucrose-rich diet-induced hyperlipidemic rats, the GCG-rich tea catechins exhibited strong activity in reducing plasma cholesterol and triglyceride concentrations. Furthermore, the hepatic cholesterol and triglyceride concentrations that had increased as a result of the sucrose-rich diet were reduced due to GCG-rich tea catechins consumption. In order to investigate the hyperlipidemic mechanism of GCG-rich tea catechins, we examined the hepatic expressions of LDL receptor and HMG-CoA reductase in hyperlipidemic rats. We further evaluated the action of purified GCG on LDL receptor activity, which is a key contributor to the regulation of cholesterol concentrations. We found that purified GCG increased LDL receptor protein level and activity to a greater extent than EGCG. In conclusion, our study indicates that GCG-rich tea catechins in tea beverages may be effective in preventing hyperlipidemia by lowering plasma and hepatic cholesterol concentrations.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18365267     DOI: 10.1007/s11745-008-3167-4

Source DB:  PubMed          Journal:  Lipids        ISSN: 0024-4201            Impact factor:   1.880


  43 in total

1.  Secretion of hepatocyte apoB is inhibited by the flavonoids, naringenin and hesperetin, via reduced activity and expression of ACAT2 and MTP.

Authors:  L J Wilcox; N M Borradaile; L E de Dreu; M W Huff
Journal:  J Lipid Res       Date:  2001-05       Impact factor: 5.922

Review 2.  Role of oxidized low density lipoprotein in atherogenesis.

Authors:  J L Witztum; D Steinberg
Journal:  J Clin Invest       Date:  1991-12       Impact factor: 14.808

3.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.

Authors:  W T Friedewald; R I Levy; D S Fredrickson
Journal:  Clin Chem       Date:  1972-06       Impact factor: 8.327

4.  Epigallocatechin gallate and caffeine differentially inhibit the intestinal absorption of cholesterol and fat in ovariectomized rats.

Authors:  Shu Wang; Sang K Noh; Sung I Koo
Journal:  J Nutr       Date:  2006-11       Impact factor: 4.798

5.  Walnut-enriched diet increases the association of LDL from hypercholesterolemic men with human HepG2 cells.

Authors:  S Muñoz; M Merlos; D Zambón; C Rodríguez; J Sabaté; E Ros; J C Laguna
Journal:  J Lipid Res       Date:  2001-12       Impact factor: 5.922

Review 6.  Effects of tea consumption on nutrition and health.

Authors:  C S Yang; J M Landau
Journal:  J Nutr       Date:  2000-10       Impact factor: 4.798

Review 7.  Green tea and its polyphenolic catechins: medicinal uses in cancer and noncancer applications.

Authors:  Nurulain T Zaveri
Journal:  Life Sci       Date:  2006-01-30       Impact factor: 5.037

8.  Polyunsaturated fatty acids downregulate the low density lipoprotein receptor of human HepG2 cells.

Authors:  Sebely Pal; Andrew M. Thomson; Cynthia D.K. Bottema; Paul D. Roach
Journal:  J Nutr Biochem       Date:  2002-01       Impact factor: 6.048

9.  Direct inhibition of the ubiquitin-proteasome pathway by ester bond-containing green tea polyphenols is associated with increased expression of sterol regulatory element-binding protein 2 and LDL receptor.

Authors:  Deborah J Kuhn; Audrey C Burns; Aslamuzzaman Kazi; Q Ping Dou
Journal:  Biochim Biophys Acta       Date:  2004-06-01

10.  A green tea catechin extract upregulates the hepatic low-density lipoprotein receptor in rats.

Authors:  Christina A Bursill; Paul D Roach
Journal:  Lipids       Date:  2007-06-21       Impact factor: 1.880

View more
  14 in total

1.  Phase I study of topical epigallocatechin-3-gallate (EGCG) in patients with breast cancer receiving adjuvant radiotherapy.

Authors:  Hanxi Zhao; Wanqi Zhu; Li Jia; Xiaorong Sun; Guanxuan Chen; Xianguang Zhao; Xiaolin Li; Xiangjiao Meng; Lingling Kong; Ligang Xing; Jinming Yu
Journal:  Br J Radiol       Date:  2015-11-26       Impact factor: 3.039

2.  Effects of (-)-gallocatechin-3-gallate on tetrodotoxin-resistant voltage-gated sodium channels in rat dorsal root ganglion neurons.

Authors:  Yan Zhang; Yan-Yan Jia; Jin-Lei Guo; Pei-Qing Liu; Jian-Min Jiang
Journal:  Int J Mol Sci       Date:  2013-05-07       Impact factor: 5.923

3.  The differential effects of green tea on dose-dependent doxorubicin toxicity.

Authors:  Slawomir Mandziuk; Renata Gieroba; Agnieszka Korga; Wlodzimierz Matysiak; Barbara Jodlowska-Jedrych; Franciszek Burdan; Ewa Poleszak; Michał Kowalczyk; Luiza Grzycka-Kowalczyk; Elzbieta Korobowicz; Aleksandra Jozefczyk; Jaroslaw Dudka
Journal:  Food Nutr Res       Date:  2015-12-21       Impact factor: 3.894

4.  Preventive role of green tea catechins from obesity and related disorders especially hypercholesterolemia and hyperglycemia.

Authors:  Rabia Shabir Ahmad; Masood Sadiq Butt; M Tauseef Sultan; Zarina Mushtaq; Shakeel Ahmad; Saikat Dewanjee; Vincenzo De Feo; Muhammad Zia-Ul-Haq
Journal:  J Transl Med       Date:  2015-03-04       Impact factor: 5.531

5.  Long non-coding RNAs expression profile in HepG2 cells reveals the potential role of long non-coding RNAs in the cholesterol metabolism.

Authors:  Gang Liu; Xinxin Zheng; Yanlu Xu; Jie Lu; Jingzhou Chen; Xiaohong Huang
Journal:  Chin Med J (Engl)       Date:  2015-01-05       Impact factor: 2.628

6.  Formulation and characterization of EGCG for the treatment of superficial bladder cancer.

Authors:  Katarzyna Dettlaff; Maciej Stawny; Magdalena Ogrodowczyk; Anna Jelińska; Waldemar Bednarski; Dorota Wątróbska-Świetlikowska; Rick W Keck; Omar A Khan; Ibrahim H Mostafa; Jerzy Jankun
Journal:  Int J Mol Med       Date:  2017-06-14       Impact factor: 4.101

7.  Green tea halts progression of cardiac transthyretin amyloidosis: an observational report.

Authors:  Arnt V Kristen; Stephanie Lehrke; Sebastian Buss; Derliz Mereles; Henning Steen; Philipp Ehlermann; Stefan Hardt; Evangelos Giannitsis; Rupert Schreiner; Uwe Haberkorn; Philipp A Schnabel; Reinhold P Linke; Christoph Röcken; Erich E Wanker; Thomas J Dengler; Klaus Altland; Hugo A Katus
Journal:  Clin Res Cardiol       Date:  2012-05-15       Impact factor: 5.460

8.  Effect of Dietary Cocoa Tea (Camellia ptilophylla) Supplementation on High-Fat Diet-Induced Obesity, Hepatic Steatosis, and Hyperlipidemia in Mice.

Authors:  Xiao Rong Yang; Elaine Wat; Yan Ping Wang; Chun Hay Ko; Chi Man Koon; Wing Sum Siu; Si Gao; David Wing Shing Cheung; Clara Bik San Lau; Chuang Xing Ye; Ping Chung Leung
Journal:  Evid Based Complement Alternat Med       Date:  2013-07-09       Impact factor: 2.629

9.  Cocoa tea (Camellia ptilophylla) water extract inhibits adipocyte differentiation in mouse 3T3-L1 preadipocytes.

Authors:  Kai Kai Li; Chuek Lun Liu; Hoi Ting Shiu; Hing Lok Wong; Wing Sum Siu; Cheng Zhang; Xiao Qiang Han; Chuang Xing Ye; Ping Chung Leung; Chun Hay Ko
Journal:  Sci Rep       Date:  2016-02-01       Impact factor: 4.379

Review 10.  Can EGCG Alleviate Symptoms of Down Syndrome by Altering Proteolytic Activity?

Authors:  Marzena Wyganowska-Świątkowska; Maja Matthews-Kozanecka; Teresa Matthews-Brzozowska; Ewa Skrzypczak-Jankun; Jerzy Jankun
Journal:  Int J Mol Sci       Date:  2018-01-15       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.